Literature DB >> 11054294

Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site.

M Laurberg1, O Kristensen, K Martemyanov, A T Gudkov, I Nagaev, D Hughes, A Liljas.   

Abstract

The crystal structure of Thermus thermophilus elongation factor G (EF-G) carrying the point mutation His573Ala was determined at a resolution of 2.8 A. The mutant has a more closed structure than that previously reported for wild-type EF-G. This is obtained by a 10 degrees rigid rotation of domains III, IV and V with regard to domains I and II. This rotation results in a displacement of the tip of domain IV by approximately 9 A. The structure of domain III is now fully visible and reveals the double split beta-alpha-beta motif also observed for EF-G domain V and for several ribosomal proteins. A large number of fusidic acid resistant mutations found in domain III have now been possible to locate. Possible locations for the effector loop and a possible binding site for fusidic acid are discussed in relation to some of the fusidic acid resistant mutations. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054294     DOI: 10.1006/jmbi.2000.4168

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  58 in total

1.  Rapid evolution in conformational space: a study of loop regions in a ubiquitous GTP binding domain.

Authors:  Christian Blouin; Davin Butt; Andrew James Roger
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

2.  Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocation.

Authors:  Christian M T Spahn; Maria G Gomez-Lorenzo; Robert A Grassucci; Rene Jørgensen; Gregers R Andersen; Roland Beckmann; Pawel A Penczek; Juan P G Ballesta; Joachim Frank
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

3.  eIF5B employs a novel domain release mechanism to catalyze ribosomal subunit joining.

Authors:  Bernhard Kuhle; Ralf Ficner
Journal:  EMBO J       Date:  2014-03-31       Impact factor: 11.598

4.  Role and timing of GTP binding and hydrolysis during EF-G-dependent tRNA translocation on the ribosome.

Authors:  Berthold Wilden; Andreas Savelsbergh; Marina V Rodnina; Wolfgang Wintermeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-29       Impact factor: 11.205

5.  Gaussian-weighted RMSD superposition of proteins: a structural comparison for flexible proteins and predicted protein structures.

Authors:  Kelly L Damm; Heather A Carlson
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

6.  Crystallization and preliminary X-ray analysis of a class II release factor RF3 from a sulfate-reducing bacterium.

Authors:  Kiyohito Kihira; Shuko Numata; Masaya Kitamura; Jun Kondo; Shinichi Terawaki; Yasuhito Shomura; Hirofumi Komori; Naoki Shibata; Yoshiki Higuchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-06-11

7.  Conformational changes in switch I of EF-G drive its directional cycling on and off the ribosome.

Authors:  Cristina Ticu; Roxana Nechifor; Boray Nguyen; Melanie Desrosiers; Kevin S Wilson
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

8.  Flexible fitting of high-resolution x-ray structures into cryoelectron microscopy maps using biased molecular dynamics simulations.

Authors:  Marek Orzechowski; Florence Tama
Journal:  Biophys J       Date:  2008-10-10       Impact factor: 4.033

9.  PCR-based ordered genomic libraries: a new approach to drug target identification for Streptococcus pneumoniae.

Authors:  Aimee E Belanger; Angel Lai; Marcia A Brackman; Donald J LeBlanc
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Fusidic acid-resistant mutants of Salmonella enterica serovar typhimurium have low levels of heme and a reduced rate of respiration and are sensitive to oxidative stress.

Authors:  Mirjana Macvanin; Andras Ballagi; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.